The new platform combines M42’s advanced AI capabilities with Diaverum’s 35 years of renal care expertise to make trusted, personalized kidney-health education more accessible worldwide
Explore MoreM42, a global health leader powered by artificial intelligence (AI), technology and genomics, has been recognized by the Ministry of Health and Prevention (MoHAP)
Explore MoreM42 is strengthening its UAE healthcare portfolio with 100 per cent ownership of United Eastern Medical Services’ assets, while Olive Rock Partners takes 100 per cent ownership of HealthPlus IVF & Women’s Health Abu Dhabi
Explore MoreLaunch groundbreaking effort to advance precision medicine by delivering pharmacogenomic insight at the point of care
Explore MoreM42 formalizes its 12-year presence in the Kingdom at the Global Health Exhibition in Riyadh, reinforcing alignment with Vision 2030 and commitment to preventive, data-driven healthcare
Explore MorePartnership supports the next phase of the Emirate's ambition to translate genomic insights into advanced therapies, clinical re...
Collaboration will expand clinical training and research pathways for RCSI Medical University of Bahrain students through access...
M42’s National Reference Laboratory (NRL), a leading provider of diagnostic services in the region has collaborated with digital...
M42, a global health leader powered by technology, artificial intelligence, and genomics, and Arcera Life Sciences (“Arcera”), a...
The new platform combines M42’s advanced AI capabilities with Diaverum’s 35 years of renal care expertise to make trusted, perso...
